Home/ Products / Biosimilar Antibodies
DMS2246-100ug
100ug
$350
| note | Other commonly used names in publications refering to this antibody: MOR208, XmAb5574, XmAb?5574, MOR-00208, MOR-208, XENP-5574, XMP-5574, XmAb-5574, Xmab-CD19, Xmab5574, tafasitamab-cxix |
| target | CD19 |
| alias | CD19,B4,CVID3,MGC12802 |
| gene id | Uniprot ID: P15391 |
| host species | Humanized |
| reactivity | Human |
| iso type | Human IgG1-G2 kappa |
| formulation | Lyophilized from sterile PBS, pH 7.4. Typically, 5% - 8% trehalose is added as a protective agent prior to lyophilization. |
| reconstitution | Reconstitute lyophilized powder with water to a concentration of 100 ug/ml |
| applications | ELISA |
| dilution | ELISA 1:5000-10000 |
| shipping | Shipped at ambient conditions. |
| storage | Lyophilized form is stable for 1 week at room temperature. Store at -20 °C to -80 °C for 12 months in lyophilized form. After reconstitution, store at 4 °C for 2-7 days or at below -20 °C for up to 3 months. |
ELISA plate pre-coated with2 ug/mL (100 uL/well) Human CD19 (M75I,L82V,F83L), hFc Tag can bind to Anti-CD19 (tafasitamab biosimilar) mAb in a linear range of 3.2-80 ng/mL.
DMS2246-100ug
100ug
$350